Abiopharma

New Form 8-K - COGNITION THERAPEUTICS INC Filed: 2025-08-26 AccNo: 0001104659-25-083059 Size: 187 KB Item 8.01: Other Events

Director FOEHR MATTHEW W 🟢 acquired 540.5K shares of OmniAb, Inc. (OABI) at $1.85 Transaction Date: Aug 26, 2025 | Filing ID: 000009

Arcturus Therapeutics to Attend Upcoming Investor Conferences

New Form 6-K - SciSparc Ltd. Filed: 2025-08-26 AccNo: 0001213900-25-080737 Size: 12 KB

Neurocrine Biosciences to Present at Upcoming Investor Conferences in September

Altamira Therapeutics to Host First Half 2025 Financial Results and Business Update Call on August 29, 2025

Cognition Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences

BioXcel Therapeutics To Announce Topline Results from SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia on August 27, 2025

Dolby Cinema vs IMAX: A 2025 Comparison of Premium Theater Experiences

The Latest on The Super Mario Bros. Movie 2: What We Know So Far

ASEN R SCOTT 🟢 acquired 5.9K shares of DURECT CORP (DRRX) at $1.92 Transaction Date: Aug 22, 2025 | Filing ID: 025520

Notification from BriaCell Therapeutics Corp.

The Latest on 23andMe: Bankruptcy Fallout and What’s Next

Amazon Fire HD 10 Tablet Review and Guide